tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TVRD Stock Latest News

Tvardi Therapeutics: Buy Rating Driven by Promising TTI-101 Trial Prospects
RatingsTvardi Therapeutics: Buy Rating Driven by Promising TTI-101 Trial Prospects
11d ago
TVRD
Tvardi Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
Tvardi Therapeutics Reports Q2 2025 Financial Results
20d ago
TVRD
Eight option delistings on August 18th
PremiumThe Fly
Eight option delistings on August 18th
20d ago
ABTS
ALUR
Tvardi Therapeutics Faces Legal and Financial Risks from Exclusive Forum Provision
PremiumCompany Announcements
Tvardi Therapeutics Faces Legal and Financial Risks from Exclusive Forum Provision
23d ago
TVRD
Tvardi Therapeutics reports Q2 EPS ($1.00) vs ($2.71) last year
PremiumThe Fly
Tvardi Therapeutics reports Q2 EPS ($1.00) vs ($2.71) last year
24d ago
TVRD
Tvardi Therapeutics expects cash to fund operations into Q4 2026
PremiumThe FlyTvardi Therapeutics expects cash to fund operations into Q4 2026
24d ago
TVRD
Tvardi Therapeutics management to meet with Piper Sandler
Premium
The Fly
Tvardi Therapeutics management to meet with Piper Sandler
2M ago
TVRD
Tvardi Therapeutics initiated with an Outperform at Raymond James
Premium
The Fly
Tvardi Therapeutics initiated with an Outperform at Raymond James
2M ago
TVRD
Tvardi Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Tvardi Therapeutics initiated with an Overweight at Cantor Fitzgerald
2M ago
TVRD
Coinbase, Datadog, Tvardi, CF, Conagra: Trending by Analysts
PremiumWeekend Updates
Coinbase, Datadog, Tvardi, CF, Conagra: Trending by Analysts
3M ago
CF
CAG
Tvardi Therapeutics initiated with an Overweight at Piper Sandler
PremiumThe Fly
Tvardi Therapeutics initiated with an Overweight at Piper Sandler
3M ago
TVRD
Tvardi Therapeutics Updates Corporate Presentation on Therapies
PremiumCompany Announcements
Tvardi Therapeutics Updates Corporate Presentation on Therapies
3M ago
8K
TVRD
Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & IdeasOppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks
3M ago
TVRD
VYGR
Tvardi Therapeutics files to sell 2.08M shares of common stock for holders
Premium
The Fly
Tvardi Therapeutics files to sell 2.08M shares of common stock for holders
3M ago
TVRD
Buy Rating for Tvardi Therapeutics Driven by Promising Phase 2 Trial Results and Growth Potential
Premium
Ratings
Buy Rating for Tvardi Therapeutics Driven by Promising Phase 2 Trial Results and Growth Potential
3M ago
TVRD
Tvardi Therapeutics completes enrollment in TTI-101 trial
PremiumThe Fly
Tvardi Therapeutics completes enrollment in TTI-101 trial
3M ago
TVRD
Tvardi Completes Enrollment for Phase 2 IPF Trial
PremiumCompany Announcements
Tvardi Completes Enrollment for Phase 2 IPF Trial
3M ago
8K
TVRD
UnitedHealth downgraded, Home Depot upgraded: Wall Street’s top analyst calls
PremiumThe Fly
UnitedHealth downgraded, Home Depot upgraded: Wall Street’s top analyst calls
4M ago
HD
AZO
Tvardi Therapeutics initiated with an Outperform at Oppenheimer
PremiumThe Fly
Tvardi Therapeutics initiated with an Outperform at Oppenheimer
4M ago
TVRD
Promising Developments and Strong Financial Position Drive Buy Rating for Tvardi Therapeutics
PremiumRatingsPromising Developments and Strong Financial Position Drive Buy Rating for Tvardi Therapeutics
4M ago
TVRD
Tvardi Therapeutics initiated with a Buy at BTIG
Premium
The Fly
Tvardi Therapeutics initiated with a Buy at BTIG
4M ago
TVRD
Tvardi Therapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
Tvardi Therapeutics Reports Q1 2025 Financial Results
4M ago
TVRD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >